Boom Or Bust? Where Will Prothena Corporation plc (NASDAQ: PRTA) Stock Go Next? – Marketing Sentinel
Home  »  Technologies   »  Boom Or Bust? Where Will Prothena Corporation plc ...

Boom Or Bust? Where Will Prothena Corporation plc (NASDAQ: PRTA) Stock Go Next?

During the last session, Prothena Corporation plc (NASDAQ:PRTA)’s traded shares were 0.66 million, with the beta value of the company hitting 1.35. At the end of the trading day, the stock’s price was $26.30, reflecting an intraday gain of 6.87% or $1.69. The 52-week high for the PRTA share is $79.75, that puts it down -203.23 from that peak though still a striking 19.01% gain since the share price plummeted to a 52-week low of $21.30. The company’s market capitalization is $1.20B, and the average trade volume was 428.63K shares over the past three months.

Prothena Corporation plc (PRTA) received a consensus recommendation of a Buy from analysts. That translates to a mean rating of 1.70. PRTA has a Sell rating from 0 analyst(s) out of 7 analysts who have looked at this stock. 1 analyst(s) recommend to Hold the stock while 0 suggest Overweight, and 6 recommend a Buy rating for it. 0 analyst(s) has rated the stock Underweight. Company’s earnings per share (EPS) for the current quarter are expected to be -$0.57.

3 Tiny Stocks Primed to Explode The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.

We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.

Click here for full details and to join for free

Prothena Corporation plc (NASDAQ:PRTA) trade information

Prothena Corporation plc (PRTA) registered a 6.87% upside in the last session and has traded in the red over the past 5 sessions. The stock spiked 6.87% in intraday trading to $26.30 this Friday, 05/13/22, hitting a weekly high. The stock’s 5-day price performance is -11.72%, and it has moved by -29.87% in 30 days. Based on these gigs, the overall price performance for the year is 14.45%.

The consensus price target of analysts on Wall Street is $69.29, which implies an increase of 62.04% to the stock’s current value. The extremes of the forecast give a target low and a target high price of $45.00 and $100.00 respectively. As a result, PRTA is trading at a discount of -280.23% off the target high and -71.1% off the low.

Prothena Corporation plc (PRTA) estimates and forecasts

Statistics show that Prothena Corporation plc has underperformed its competitors in share price, compared to the industry in which it operates. Prothena Corporation plc (PRTA) shares have gone down -53.46% during the last six months, with a year-to-date growth rate less than the industry average at -283.33% against -0.10. Yet analysts are ramping up their growth forecast for the fiscal year 2022. Revenue is predicted to shrink -198.30% this quarter and then drop -128.20% in the quarter after that. In the rating firms’ projections, revenue will decrease -70.20% compared to the previous financial year.

Revenue for the current quarter is expected to be $16.04 million as predicted by 5 analyst(s). Meanwhile, a consensus of 5 analyst(s) estimates revenue growth to $27.28 million by the end of Sep 2022.

An analysis of the company’s performance over the past 5 years shows that the company’s earnings grew an estimated 18.10%. While earnings are projected to return 149.60% in 2022, the next five years will return -0.60% per annum.

PRTA Dividends

Prothena Corporation plc is due to release its next quarterly earnings on May 05. However, it is important to remember that the dividend yield ratio is merely an indicator meant to only serve as guidance.

Prothena Corporation plc (NASDAQ:PRTA)’s Major holders

Prothena Corporation plc insiders own 0.08% of total outstanding shares while institutional holders control 93.18%, with the float percentage being 93.25%. EcoR1 Capital, LLC is the largest shareholder of the company, while 268 institutions own stock in it. As of Dec 30, 2021, the company held over 11.28 million shares (or 24.14% of all shares), a total value of $557.44 million in shares.

The next largest institutional holding, with 5.95 million shares, is of Price (T.Rowe) Associates Inc’s that is approximately 12.73% of outstanding shares. At the market price on Dec 30, 2021, these shares were valued at $293.87 million.

Also, the Mutual Funds coming in first place with the largest holdings of Prothena Corporation plc (PRTA) shares are Price (T.Rowe) New Horizons Fund and SPDR (R) Ser Tr-SPDR (R) S&P (R) Biotech ETF. Data provided on Dec 30, 2021 indicates that Price (T.Rowe) New Horizons Fund owns about 1.45 million shares. This amounts to just over 3.11 percent of the company’s overall shares, with a $71.86 million market value. The same data shows that the other fund manager holds slightly less at 1.41 million, or about 3.02% of the stock, which is worth about $48.13 million.

Leave a Comment

Your email address will not be published.

On Key

Related Posts